Baidu
map

Lancet Oncol:肥胖增加癌症发生风险

2015-02-05 Jessie Li 译 MedSci原创

背景:高体质指数(即高BMI,定义为大于等于25kg/m2)是多种慢性疾病和死亡的危险因素。全世界的超重和肥胖问题不断加重,由此对健康造成的危害引起了人们的关注。多项研究显示,高BMI与癌症发生风险增高有关,包括食管腺癌、结肠癌、直肠癌、肾癌、胰腺癌、女性胆囊癌、绝经后乳腺癌、卵巢癌及子宫内膜癌。但已有研究未考虑高BMI导致新发癌症的时滞(lag time,即高BMI导致癌症的发生需要一定的时间)

背景:


高体质指数(即高BMI,定义为大于等于25kg/m2)是多种慢性疾病和死亡的危险因素。全世界的超重和肥胖问题不断加重,由此对健康造成的危害引起了人们的关注。多项研究显示,高BMI与癌症发生风险增高有关,包括食管腺癌、结肠癌、直肠癌、肾癌、胰腺癌、女性胆囊癌、绝经后乳腺癌卵巢癌及子宫内膜癌。但已有研究未考虑高BMI导致新发癌症的时滞(lag time,即高BMI导致癌症的发生需要一定的时间)及相关的危险因素,如激素替代治疗(hormone replacement therapy,HRT)和吸烟。本研究考虑了时滞和相关危险因素,分析了2012年由于高BMI导致的癌症全球负担增加情况,目的是为公共卫生政策和将来的研究提供依据。

方法:

在该基于人群的研究中,研究者运用相对危险度(relative risks,RR)和成人的BMI值(根据不同年龄层、性别和国别划分)来计算人群归因分值(population attributable fractions,PAFs)。并假设高BMI与癌症发生之间具有10年的时间滞后,因此运用2002年的BMI数据和GLOBOCAN2012的癌症数据来计算人群归因分值,由此估计由于高BMI导致的新发癌症病例数。研究者还根据有1982年BMI记录的数据,估计了由于1982年后保持BMI在稳定的水平而可能避免癌症的比例。研究者还进行了二次分析:验证该模型并估计激素替代治疗的使用和吸烟在其中所起的作用。

结果
研究者发现,2012年,在界范围内有481 000例(3.6%)的成人(加上10年的滞后期后大于等于30岁的)新发癌症病例是由于高BMI所致。女性的人群归因分值高于男性(5.4% vs. 1.9%)。在非常高和高人类发展指数(human development indices,HDIs)的国家,由此增加的癌症负担(PAF:5.3% vs. 4.8%)要高于中人类发展指数(1.6%)和低人类发展指数(1.0%)的国家。在高BMI导致的新发癌症病例中,子宫体癌、绝境后乳腺癌和结肠癌占据63.6%。2012年与高BMI有关的癌症病例中有1/4(约118 000例)是由于这些患者在1982年后BMI增加所致。

该研究结果强调,全球应一起努力来减少不断增加的高BMI人口数。假设高BMI与癌症之间是因果关系,那么,继续现在这种人口体重不断增加的生存模式将会导致将来的癌症负担不断增加。

原始出处:

Arnold M, Pandeya N, Byrnes G, Renehan AG, Stevens GA, Ezzati M, Ferlay J, Miranda JJ, Romieu I, Dikshit R, Forman D, Soerjomataram I. Global burden of cancer attributable to high body-mass index in 2012: a population-based study.Lancet Oncol. 2015 Jan;16(1):36-46.

本文是MedSci原创编译整理,欢迎转载!转载请注明来源并附原文链接。谢谢!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1827997, encodeId=591e182e997c5, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun May 24 22:06:00 CST 2015, time=2015-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864600, encodeId=49c918646004a, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Oct 08 17:06:00 CST 2015, time=2015-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16077, encodeId=f14c160e7b6, content=i 有, beContent=null, objectType=article, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce01615276, createdName=Johnny1989, createdTime=Mon Feb 16 15:36:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15901, encodeId=d36d159019f, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:40:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15200, encodeId=880d152006a, content=类似研究会越来越多, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.168.**, createdTime=Thu Feb 05 22:54:00 CST 2015, time=2015-02-05, status=1, ipAttribution=)]
    2015-05-24 howi
  2. [GetPortalCommentsPageByObjectIdResponse(id=1827997, encodeId=591e182e997c5, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun May 24 22:06:00 CST 2015, time=2015-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864600, encodeId=49c918646004a, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Oct 08 17:06:00 CST 2015, time=2015-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16077, encodeId=f14c160e7b6, content=i 有, beContent=null, objectType=article, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce01615276, createdName=Johnny1989, createdTime=Mon Feb 16 15:36:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15901, encodeId=d36d159019f, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:40:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15200, encodeId=880d152006a, content=类似研究会越来越多, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.168.**, createdTime=Thu Feb 05 22:54:00 CST 2015, time=2015-02-05, status=1, ipAttribution=)]
    2015-10-08 minlingfeng
  3. [GetPortalCommentsPageByObjectIdResponse(id=1827997, encodeId=591e182e997c5, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun May 24 22:06:00 CST 2015, time=2015-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864600, encodeId=49c918646004a, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Oct 08 17:06:00 CST 2015, time=2015-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16077, encodeId=f14c160e7b6, content=i 有, beContent=null, objectType=article, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce01615276, createdName=Johnny1989, createdTime=Mon Feb 16 15:36:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15901, encodeId=d36d159019f, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:40:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15200, encodeId=880d152006a, content=类似研究会越来越多, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.168.**, createdTime=Thu Feb 05 22:54:00 CST 2015, time=2015-02-05, status=1, ipAttribution=)]
    2015-02-16 Johnny1989

    i 有

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1827997, encodeId=591e182e997c5, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun May 24 22:06:00 CST 2015, time=2015-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864600, encodeId=49c918646004a, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Oct 08 17:06:00 CST 2015, time=2015-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16077, encodeId=f14c160e7b6, content=i 有, beContent=null, objectType=article, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce01615276, createdName=Johnny1989, createdTime=Mon Feb 16 15:36:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15901, encodeId=d36d159019f, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:40:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15200, encodeId=880d152006a, content=类似研究会越来越多, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.168.**, createdTime=Thu Feb 05 22:54:00 CST 2015, time=2015-02-05, status=1, ipAttribution=)]
    2015-02-16 windmilL1989

    已阅

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1827997, encodeId=591e182e997c5, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun May 24 22:06:00 CST 2015, time=2015-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864600, encodeId=49c918646004a, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Oct 08 17:06:00 CST 2015, time=2015-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16077, encodeId=f14c160e7b6, content=i 有, beContent=null, objectType=article, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce01615276, createdName=Johnny1989, createdTime=Mon Feb 16 15:36:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15901, encodeId=d36d159019f, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:40:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15200, encodeId=880d152006a, content=类似研究会越来越多, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.168.**, createdTime=Thu Feb 05 22:54:00 CST 2015, time=2015-02-05, status=1, ipAttribution=)]
    2015-02-05 175.8.168.**

    类似研究会越来越多

    0

相关资讯

Nature:2型先天淋巴样细胞可促进脂肪米色化遏制肥胖

随着人类生活方式的西化,世界人口的肥胖率越来越高,而这一疾病通常由遗传因素和环境因素共同影响。最新研究表明包括单核细胞、粒细胞和淋巴细胞在内的免疫细胞参与了机体的稳态代谢平衡调控,但是在肥胖的个体中研究者们发现这些免疫细胞的功能出现了异常。 2型先天淋巴样细胞(ILC2s)能够调控获得性免疫反应以及嗜酸性粒细胞和可变激活巨噬细胞产生的免疫反应。近年来研究者们从小鼠的白色脂肪组织(WAT)中分离到

AJCN:孕前改善机体健康或可有效抑制后代肥胖

近日,一项刊登在国际杂志The American Journal of Clinical Nutrition上的研究论文中,来自南安普顿大学的研究人员通过研究发现,女性孕前改善机体健康或者可以帮助有效预防个体后代肥胖;文章中研究者为揭示儿童早期生长环境和后期患肥胖间的关系又提供了新的研究证据,此前研究者鉴别出了一系列风险因子,但却很少评估其对肥胖的联合效应。 这项研究中研究者发现了许多可以预

Cell Metab:限时饮食可以预防甚至逆转肥胖

长期以来,母亲们都认为不宜在半夜吃零食,科学家们对此也持有相同的看法。但直到几年前,人们也只是有此怀疑,却没有多少科学证据可以支持它。现在,一项在小鼠中进行的新研究显示,即使有时候它们的饮食不够健康,但只要不是一天到晚吃个不停,就可避免肥胖和代谢问题。 在此前的一项研究中,美国圣地亚哥索尔克生物研究所(Salk Institute for Biological Studies)和其他机构的研究

Diabetes:脂联素抗炎记——肥胖群体中也有“好”胖子?

近日,国际糖尿病学杂志Diabetes 刊登了来自曼彻斯特大学David W. Ray研究小组的一项最新研究成果,他们发现在肥胖人群中,一种TLR信号负调控因子A20的表达与胰岛素敏感性呈明显相关性,并且在经过肥胖症治疗手术之后的个体中,A20的表达与血清中脂联素呈现明显的正相关性并伴随代谢和炎症的改善,该小组通过小鼠模型证明了A20对于脂联素发挥抗炎效应具有调控作用。 研究人员指出,脂联素是白

Science:新生脂肪可帮助对抗细菌感染

在一个崇尚“纤瘦美”的社会里,任何与“脂肪”有关的物质仿佛都成了不好的东西。许多人提起自己体内存在的大量脂肪就深感恐惧,更别提“臭名昭著”的胆固醇了。实际上,身体内的各种物质各司其职,即使被很多人厌恶的脂肪,也在人体的正常运作中扮演着重要作用。脂肪层能够保护脏器,维持体温,乃至在免疫过程中发挥重要作用。发表在最新一期《科学》杂志上的研究成果指出,分化中的皮下脂肪组织能够分泌一种抗菌肽并杀死金黄色葡

点评:继续寻找2型糖尿病的基因是否有价值?

2型糖尿病是一种高度异质性的疾病,在复杂的基因背景下,营养物质过多摄入导致体内糖脂代谢异常,引起疾病发生。因此,遗传和环境是2型糖尿病发生的两大重要方面。正方Mark McCarthy和反方Mike Lean正是从这两个方面来看待目前关于2型糖尿病的研究。在遗传学方面,正如Mark McCarthy所说,通过GWAS研究和一些表观遗传学的研究从基础研究的角度在一定程度上揭示了基因在2型糖尿病发生中

Baidu
map
Baidu
map
Baidu
map